Cogent Biosciences, Inc. - COM (COGT)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
121M
Holdings value Q2 2024
$1.02B
Value change Q2 2024
+$106M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
145
Number of buys Q2 2024
35
Number of sells Q2 2024
-15
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 7.06M $76.7M +$7.01M $10.80 56
2024 Q2 121M $1.02B +$106M $8.43 145
2024 Q1 109M $734M +$128M $6.72 145
2023 Q4 90.8M $534M -$45.4M $5.88 142
2023 Q3 90.9M $886M +$20.5M $9.75 134
2023 Q2 88.5M $1.05B +$159M $11.84 134
2023 Q1 75.2M $810M +$3.23M $10.79 133
2022 Q4 74.7M $863M -$1.8M $11.56 132
2022 Q3 73.7M $1.1B +$70.6M $14.92 128
2022 Q2 70.1M $632M +$209M $9.02 107
2022 Q1 47.2M $354M -$5.66M $7.49 81
2021 Q4 44.9M $385M +$41.8M $8.58 80
2021 Q3 36.8M $310M +$4.14M $8.41 71
2021 Q2 35M $284M +$12.9M $8.11 65
2021 Q1 34.4M $303M +$9.82M $8.78 65
2020 Q4 33.5M $376M +$318M $11.23 67